Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents

Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.